GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Applied DNA Sciences Inc (STU:UDJ) » Definitions » Change In Receivables

Applied DNA Sciences (STU:UDJ) Change In Receivables : €1.40 Mil (TTM As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Applied DNA Sciences Change In Receivables?

Applied DNA Sciences's change in receivables for the quarter that ended in Mar. 2024 was €0.04 Mil. It means Applied DNA Sciences's Accounts Receivable declined by €0.04 Mil from Dec. 2023 to Mar. 2024 .

Applied DNA Sciences's change in receivables for the fiscal year that ended in Sep. 2023 was €2.86 Mil. It means Applied DNA Sciences's Accounts Receivable declined by €2.86 Mil from Sep. 2022 to Sep. 2023 .

Applied DNA Sciences's Accounts Receivable for the quarter that ended in Mar. 2024 was €0.38 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Applied DNA Sciences's Days Sales Outstanding for the three months ended in Mar. 2024 was 40.08.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Applied DNA Sciences's liquidation value for the three months ended in Mar. 2024 was €-5.27 Mil.


Applied DNA Sciences Change In Receivables Historical Data

The historical data trend for Applied DNA Sciences's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied DNA Sciences Change In Receivables Chart

Applied DNA Sciences Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.51 -2.24 -0.54 2.86

Applied DNA Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.95 1.16 0.38 -0.18 0.04

Applied DNA Sciences Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Applied DNA Sciences  (STU:UDJ) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Applied DNA Sciences's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.376/0.856*91
=40.08

2. In Ben Graham's calculation of liquidation value, Applied DNA Sciences's accounts receivable are only considered to be worth 75% of book value:

Applied DNA Sciences's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2.898-8.603+0.75 * 0.376+0.5 * 0.309
=-5.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Applied DNA Sciences Change In Receivables Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Applied DNA Sciences (STU:UDJ) Business Description

Traded in Other Exchanges
Address
50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Applied DNA Sciences (STU:UDJ) Headlines

No Headlines